What is Atezolizumab Injection used for?
Urothelial carcinoma (a kind of bladder cancer) that has spread throughout the body (metastatic) or cannot be removed by surgery is treated with an atezolizumab injection (advanced).
Can atezolizumab cure cancer?
Atezolizumab is a drug that is used to treat advanced (metastatic) cancers such as lung cancer. Breast cancer is triple-negative. hepatic carcinoma is a disease that affects the liver.
Is atezolizumab a chemotherapy?
It inhibits cancer cell growth and division, and it has the potential to destroy cancer cells. In the treatment of patients with recurrent or metastatic head and neck malignancies, the addition of bevacizumab to standard chemotherapy or a combination of bevacizumab and atezolizumab may be more effective than regular chemotherapy plus cetuximab.
What type of treatment is atezolizumab?
Atezolizumab is an immunotherapy medication. This medication is used to treat a variety of cancers. Depending on your situation, you may receive atezolizumab alone or in combination with other medications.
How successful is atezolizumab?
The overall response rate (ORR) in the IMvigor210 research was 23.5 percent of 119 patients, with 6.7 percent of patients seeing a complete response and 16.8 percent experiencing a partial response. The median duration of response (DOR) varied from 3.7 to 16.6 months, however, the final DOR has not yet been determined.
How long does atezolizumab stay in the system?
Imfinzi stays in your system for around 3 months after you receive a dose. Tecentriq stays in your system for roughly 5 months after a single dose. You might be wondering why these treatments are given every 2 to 4 weeks since they can stay in the body for months.
Does atezolizumab cause hair loss?
When administered with other anticancer treatments in individuals with lung cancer or triple-negative breast cancer, atezolizumab (Tecentriq) has been linked to hair loss (alopecia).
Is atezolizumab an immunosuppressant?
Atezolizumab is a monoclonal antibody that targets the immunosuppressive receptor PD-L1 and has been shown to be successful in a variety of illnesses, including urothelial and renal cell carcinoma, as well as non-small-cell lung cancer (15–17). Anti-PD-1 and anti-PD-L1 antibodies are used in immunotherapy to target the PD-1-PD-L1 pathway. To know more click here.
We are a Global Wholesaler and Exporter from India and Operate in more than 5 Countries like UAE, Oman, Qatar, Saudi, Myanmar, etc. If you are looking for a Product or Brand To Click here.